Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001578563-25-000202
Filing Date
2025-04-01
Accepted
2025-04-01 16:44:14
Documents
1
Period of Report
2025-03-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5586
  Complete submission text file 0001578563-25-000202.txt   7149
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850
Business Address
Truex Samantha (Reporting) CIK: 0002017156 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 25800435